Kytopen
Kytopen Corp. is a Cambridge, Massachusetts life-sciences instrument company, spun out of MIT, that builds non-viral, continuous-flow cellular engineering hardware for cell and gene therapy discovery and manufacturing. Its Flowfect technology combines continuous fluid flow with electric fields to deliver mRNA, DNA and CRISPR payloads into cells, and is sold as two benchtop platforms: Flowfect Discover, an automated small-volume system that runs up to 96 high-throughput transfections in about ten minutes, and Flowfect TX, a closed-system instrument that processes 10-50 million cells per mL at 25-50 mL per minute for GMP-scale manufacturing. The company sells laboratory instruments and consumables to biopharma and CDMO customers through a quote and technology-access motion; it publishes no developer program, no public API, and no machine-readable API contract of any kind. Instrument data integration for Flowfect customers is delivered by a third party, Ganymede Bio, under its own platform and its own contract - that surface belongs to Ganymede, not to Kytopen.
Kytopen is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Life Sciences, Cell Therapy, and Gene Delivery.
Kytopen’s developer surface includes engineering blog, support, and 4 more developer resources.
Kin Score
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Agent Surfaces 1
MCP servers, agent skills, and machine-readable catalogs
Build 1
SDKs, sample code, and the tooling you integrate with
Access & Security 1
Authentication, authorization, and security posture
Operate 1
Status, limits, changes, and where to get help
Company 2
The organization behind the API
Source (apis.yml)
Work with this as data
Every provider here is available over the APIs.io API and to AI agents over MCP.